BiorEsorbable SiroLimus-ElutIng Scaffold TreatmEnt for Below The Knee Disease ELITE-BTK Trial
Brief description of study
The purpose of this research is to is to evaluate the investigational MAGNITUDE® Bioresorbable Drug-Eluting Scaffold (MAGNITUDE Scaffold) to treat narrowed or blocked leg arteries below the knee compared to the standard of care with balloon angioplasty.
Clinical Study Identifier: s25-00130
ClinicalTrials.gov Identifier: NCT06071429
Principal Investigator:
Anvar Babaev.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.